Hoogeveen RC - Search Results

1

Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study.

Pankow JS, Duncan BB, Schmidt MI, Ballantyne CM, Couper DJ, Hoogeveen RC, Golden SH; Atherosclerosis Risk in Communities Study. Pankow JS, et al. Among authors: hoogeveen rc. Diabetes Care. 2004 Jan;27(1):77-82. doi: 10.2337/diacare.27.1.77. Diabetes Care. 2004. PMID: 14693970

2

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

Morrisett JD, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Opekun AR, Jaffe JS, Oppermann S, Kahan BD. Morrisett JD, et al. J Lipid Res. 2002 Aug;43(8):1170-80. J Lipid Res. 2002. PMID: 12177161 Free article.

3

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study. Duncan BB, et al. Diabetes. 2003 Jul;52(7):1799-805. doi: 10.2337/diabetes.52.7.1799. Diabetes. 2003. PMID: 12829649

4

Role of lipid and lipoprotein profiles in risk assessment and therapy.

Ballantyne CM, Hoogeveen RC. Ballantyne CM, et al. Among authors: hoogeveen rc. Am Heart J. 2003 Aug;146(2):227-33. doi: 10.1016/S0002-8703(02)94701-0. Am Heart J. 2003. PMID: 12891189 Review.

5

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.

Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Heiss G, Sharrett AR. Ballantyne CM, et al. Among authors: hoogeveen rc. Circulation. 2004 Feb 24;109(7):837-42. doi: 10.1161/01.CIR.0000116763.91992.F1. Epub 2004 Feb 2. Circulation. 2004. PMID: 14757686

6

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction.

Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO, Nelson KW, Ballantyne CM. Xydakis AM, et al. Among authors: hoogeveen rc. J Clin Endocrinol Metab. 2004 Jun;89(6):2697-703. doi: 10.1210/jc.2003-031826. J Clin Endocrinol Metab. 2004. PMID: 15181044

7

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G. Duncan BB, et al. Among authors: hoogeveen rc. Diabetes. 2004 Sep;53(9):2473-8. doi: 10.2337/diabetes.53.9.2473. Diabetes. 2004. PMID: 15331562

8

PLAC test for identification of individuals at increased risk for coronary heart disease.

Hoogeveen RC, Ballantyne CM. Hoogeveen RC, et al. Expert Rev Mol Diagn. 2005 Jan;5(1):9-14. doi: 10.1586/14737159.5.1.9. Expert Rev Mol Diagn. 2005. PMID: 15723587

9

Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system.

Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, Nelson KW, Ballantyne CM. Liu MY, et al. Among authors: hoogeveen rc. Clin Chem. 2005 Jul;51(7):1102-9. doi: 10.1373/clinchem.2004.047084. Clin Chem. 2005. PMID: 15976097

10

Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.

Hoogeveen RC, Morrison A, Boerwinkle E, Miles JS, Rhodes CE, Sharrett AR, Ballantyne CM. Hoogeveen RC, et al. Atherosclerosis. 2005 Dec;183(2):301-7. doi: 10.1016/j.atherosclerosis.2005.03.007. Epub 2005 Apr 14. Atherosclerosis. 2005. PMID: 16285993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters